Emmanuel Raffoux

18.0k total citations · 1 hit paper
193 papers, 7.7k citations indexed

About

Emmanuel Raffoux is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Emmanuel Raffoux has authored 193 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Hematology, 53 papers in Public Health, Environmental and Occupational Health and 50 papers in Molecular Biology. Recurrent topics in Emmanuel Raffoux's work include Acute Myeloid Leukemia Research (101 papers), Acute Lymphoblastic Leukemia research (52 papers) and Chronic Myeloid Leukemia Treatments (42 papers). Emmanuel Raffoux is often cited by papers focused on Acute Myeloid Leukemia Research (101 papers), Acute Lymphoblastic Leukemia research (52 papers) and Chronic Myeloid Leukemia Treatments (42 papers). Emmanuel Raffoux collaborates with scholars based in France, United States and Switzerland. Emmanuel Raffoux's co-authors include Hervé Dombret, Xavier Thomas, Claude Preudhomme, Nicolas Boissel, Pierre Fenaux, Claude Gardin, Stéphane de Botton, Sylvie Castaigné, Sylvie Chevret and Philippe Rousselot and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Emmanuel Raffoux

186 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

2016 336 citations Emmanuel Raffoux, Norbert Vey et al. profile →

Peers

Countries citing papers authored by Emmanuel Raffoux

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Raffoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Raffoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Raffoux more than expected).

Fields of papers citing papers by Emmanuel Raffoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Raffoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Raffoux. The network helps show where Emmanuel Raffoux may publish in the future.

Co-authorship network of co-authors of Emmanuel Raffoux

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Raffoux. A scholar is included among the top collaborators of Emmanuel Raffoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Raffoux. Emmanuel Raffoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contribution of paranasal sinus, chest, and abdomen/pelvis computed tomography in patients with febrile neutropenia 2025 ·PLoS ONE ·(unknown), É. de Kerviler, Anne Bergeron, Emmanuel Raffoux, Aliénor Xhaard, C. de Bazelaire, Constance de Margerie‐Mellon	0
2	Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia 2024 ·Blood ·Piotr Walczak, Sofiane Fodil, N. Vignal, Aurélie Cabannes‐Hamy, Nicolas Boissel, Emmanuel Raffoux, Jean‐Michel Cayuela, Lauriane Goldwirt, Étienne Lengliné	0
3	Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission 2024 ·Blood Advances ·(unknown), Étienne Lengliné, Florence Rabian, Marco Cerrano, Rathana Kim, (unknown), Dario Ferrero, Marie Sébert, Nathalie Dhédin, Raphaël Itzykson, Lionel Adès, Emmanuel Raffoux, Hervé Dombret, Ernesta Audisio, Emmanuelle Clappier, Nicolas Boissel	2
4	Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms 2021 ·Blood ·(unknown), Lin‐Pierre Zhao, Nabih Maslah, Emmanuelle Verger, (unknown), (unknown), Marine Cazaux, Nicolas Gauthier, (unknown), Emmanuelle Clappier, Nathalie Parquet, Christine Dosquet, Delphine Réa, Jean‐Marc Zini, William Vainchenker, Emmanuel Raffoux, Stéphane Giraudier, Jean‐Jacques Kiladjian, Bruno Cassinat, Lina Benajiba	20
5	Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality 2021 ·Leukemia ·(unknown), (unknown), Emmanuel Raffoux, Marie Robin, David Michonneau, Marie Sébert, (unknown), Aliénor Xhaard, Étienne Lengliné, Raphaël Itzykson, Camilla Frieri, Hervé Dombret, Pierre Fenaux, Régis Peffault de Latour, Lionel Adès, Gèrard Socié	6
6	Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet’s Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils 2020 ·Journal of Investigative Dermatology ·Marie Passet, C. Lepelletier, Marie‐Dominique Vignon‐Pennamen, François Chasset, Pierre Hirsch, Maxime Battistella, P. Duriez, Flore Sicre de Fontbrune, Nicolas Boissel, Ollivier Legrand, Emmanuel Raffoux, Martine Bagot, Lionel Adès, Emmanuelle Clappier, Jean‐David Bouaziz	24
7	Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality 2020 ·Leukemia ·(unknown), (unknown), Emmanuel Raffoux, Marie Robin, David Michonneau, Marie Sébert, (unknown), Aliénor Xhaard, Étienne Lengliné, Raphaël Itzykson, Camilla Frieri, Hervé Dombret, Pierre Fenaux, Régis Peffault de Latour, Lionel Adès, Gèrard Socié	7
8	SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN) 2020 ·Blood ·(unknown), (unknown), (unknown), Juliette Soret, Nicolas Gauthier, Emmanuelle Verger, Nabih Maslah, (unknown), Nathalie Parquet, Christine Dosquet, Delphine Réa, Jean‐Marc Zini, William Vainchenker, Emmanuel Raffoux, Stéphane Giraudier, Bruno Cassinat, Jean‐Jacques Kiladjian, Lina Benajiba	2
9	Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations 2019 ·Blood ·Jonas S. Jutzi, (unknown), (unknown), S Kaiser, Doris Steinemann, Mathijs A. Sanders, Adil S. A. Al Hinai, Annelieke Zeilemaker, (unknown), (unknown), (unknown), Konrad Aumann, Wei Wang, Emmanuel Raffoux, Bruno Cassinat, Lars Bullinger, Brigitte Schlegelberger, Peter J.M. Valk, Heike L. Pahl	20
10	Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016 2018 ·Annales de Dermatologie et de Vénéréologie ·Charlotte Hurabielle, Maxime Battistella, C. Ram‐Wolff, C. Fite, Véronique Meignin, Jacqueline Rivet, Marie‐Dominique Vignon‐Pennamen, (unknown), Emmanuel Raffoux, Bertrand Arnulf, Éric Oksenhendler, Flore Sicre de Fontbrune, Régis Peffault de Latour, Gèrard Socié, Jean‐David Bouaziz, Célèste Lebbé, Armand Bensussan, Martine Bagot	11
11	0195: Identification of patients (pts) with chronic myeloid leukemia (CML) at high risk of artery occlusive events (AOE) during treatment with the 2nd generation tyrosine kinase inhibitor (TKI) nilotinib 2015 ·Archives of Cardiovascular Diseases Supplements ·Emmanuel Messas, Tristan Mirault, Emmanuel Raffoux, (unknown), Philippe Rousselot, Hervé Dombret, Delphine Réa	1
12	Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup 2014 ·Leukemia & lymphoma ·Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux, Philippe Rousselot, Norbert Vey, Arnaud Pigneux, Norbert Ifrah, Hervé Dombret	20
13	Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis) 2014 ·European Respiratory Journal ·Maxime Patout, (unknown), Alexandre Alanio, Sophie Touratier, Emmanuel Raffoux, Francis Derouin, Jean‐Michel Molina, Stéphane Bretagne, Patricia Ribaud, Anne Bergeron	1
14	Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group 2012 ·Journal of Clinical Oncology ·Cécile Bally, Jehane Fadlallah, Guy Leverger, Yves Bertrand, Alain Robert, André Baruchel, Agnès Guerci, Christian Récher, Emmanuel Raffoux, Xavier Thomas, Thierry Leblanc, Nadia Idres, Bruno Cassinat, Norbert Vey, Christine Chomienne, Hervé Dombret, Miguel Á. Sanz, Pierre Fenaux, Lionel Adès	32
15	The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies 2011 ·Blood ·Anne Bergeron, Raphaël Porcher, Annie Sulahian, C. de Bazelaire, Karine Chagnon, Emmanuel Raffoux, Anne Vekhoff, Muriel Cornet, Françoise Isnard, Benoît Brethon, Christophe Lacroix, J.L. Poirot, (unknown), Francis Derouin, Abdellatif Tazi, Patricia Ribaud	103
16	Prophylaxie antibactérienne et antifongique chez les patients à haut risque en hématologie Enquête de pratique et forum 2011 ·Hématologie ·Ana Berceanu, Stéphane Leprêtre, Mario Ojeda‐Uribe, Eva de Berranger, (unknown), Denis Caillot, Emmanuel Raffoux, Patricia Ribaud, Anne C. M. Thiébaut, Nöel Milpied, Mauricette Michallet, Catherine Cordonnier, Raoul Herbrecht	1
17	Breakthrough zygomycosis following empirical caspofungin treatment: report of two patients with leukemia and literature review 2010 ·Pierre Sujobert, Nicolas Boissel, Anne Bergeron, Patricia Ribaud, Hervé Dombret, Olivier Lortholary, Emmanuel Raffoux	3
18	Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies 2009 ·Haematologica ·Charikleia Kelaïdi, Aspasia Stamatoullas, Odile Beyne‐Rauzy, Emmanuel Raffoux, Bruno Quesnel, A. Guerci, F. Dreyfus, Sabine Bréchignac, Christian Berthou, Thomas Prébet, Yosr Hicheri, (unknown), J. Delaunay, Marie-Pierre Gourin, (unknown), (unknown), A.-L. Taksin, Laurence Legros, Bachra Choufi, Pierre Fenaux, (unknown)	13
19	High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group 2006 ·Leukemia ·A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux, Thierry de Revel, Xavier Thomas, Nathalie Contentin, Réda Bouabdallah, Cécile Pautas, Pascal Turlure, Oumédaly Reman, Claude Gardin, Bruno Varet, Stéphane de Botton, (unknown), H. Farhat, Sylvie Chevret, Hervé Dombret, Sylvie Castaigné	226
20	In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia 2002 ·The Journal of Experimental Medicine ·Marie-Claude Guillemin, Emmanuel Raffoux, Dominique Vitoux, Scott C. Kogan, (unknown), Valérie Lallemand-Breitenbach, Jun Zhu, Anne Janin, Marie‐Thérèse Daniel, B. Gourmel, Laurent Degos, Hervé Dombret, Michel Lanotte, Hugues de Thé	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact